{"id":72101,"date":"2026-05-06T09:34:17","date_gmt":"2026-05-06T13:34:17","guid":{"rendered":"https:\/\/www.imperialcrs.com\/blog\/?p=72101"},"modified":"2026-05-06T09:34:17","modified_gmt":"2026-05-06T13:34:17","slug":"writing-clinical-trial-materials-from-early-protocol-versions","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/","title":{"rendered":"Writing Clinical Study Materials: Why Starting Early Can Be an Option"},"content":{"rendered":"<p>Clinical studies follow established timelines, and the work of preparing site and participant materials typically begins at a predictable point in that process. Most study teams assume writing begins only after the protocol is approved, and often don\u2019t consider alternatives.<\/p>\n<p>Naturally, the best time to write site and participant study materials is after the protocol is finalized. A final protocol is a reliable confirmed source: visit schedules, assessments, procedures, and language will not change without an amendment. Ideally, teams would always wait for this level of stability before writing.<\/p>\n<p>But there are situations where beginning the writing process early can be considered, especially when the protocol is moving through an extended period of internal review, scientific and medical governance review, operational refinements, and final quality checks.<\/p>\n<h2>Is Now a Good Time to Start Writing?<\/h2>\n<p>Early writing becomes appropriate when the research protocol is stable enough that its core structure is unlikely to change. Once the visit schedule, major assessments, and overall study flow are reasonably established, teams can begin shaping the research materials with the understanding that the content will be reviewed and updated where necessary later.<\/p>\n<p>Getting started early with your digital and <a href=\"https:\/\/www.imperialcrs.com\/what-we-do\/study-and-site-materials\/\">print materials<\/a> helps in two key ways that directly affect timelines and workload:<\/p>\n<h3>Momentum<\/h3>\n<p>When the protocol is finalized, instead of starting from scratch with a blank page, you\u2019re well into the writing process and closer to the finish line.<\/p>\n<h3>Visibility<\/h3>\n<p>Early writing is an opportunity to assess formats and word\u2011count realities and make decisions early. For example, a trifold brochure may need to become a four\u2011panel piece or even a booklet once you see the level of detail that\u2019s required. Or you might decide it will be more user-friendly to create separate visit guides for the main study and the extension study. This phase also gives designers enough information to begin shaping concepts, and placing draft text into early layouts helps reveal how content will fit and flow.<\/p>\n<h2>Practical Tips for Working From a Draft Clinical Trial Protocol<\/h2>\n<p>These tips can help keep your drafts accurate while the protocol is still evolving:<\/p>\n<ul>\n<li><strong>Indicate the source on every document.<\/strong> Add a simple line at the top of each document, such as \u201cWritten from protocol version dated [YYYY\/MM\/DD].\u201d This makes it clear that the content is not final and that it needs to be checked and updated.<\/li>\n<li><strong>Expect reviewers to work ahead of the protocol.<\/strong> It\u2019s common for reviewers to incorporate changes they know are coming, such as an added visit, an extra blood draw, or a new assessment, even if those updates aren\u2019t yet reflected in the draft protocol. This is why early drafts sometimes contain a mix of protocol language and assumptions, and why each document will need to be checked in its entirety later.<\/li>\n<\/ul>\n<h2>Once the Protocol Is Final<\/h2>\n<p>Once the protocol is approved, your materials need to be brought into full alignment. Treating this as a fresh and full review, not a quick patch, ensures your documents accurately reflect the study.<\/p>\n<p>It is important to review every word of every piece, even the simplest items like <a href=\"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/with-thanks-and-appreciation-strategies-for-retention-in-clinical-trials\/\">thank-you cards<\/a> and appointment cards, to verify their accuracy. And even if you know that the only change between the draft and the final is, say, one more blood draw at Visit 6, resist the temptation to make that single update and call it done. Check everything.<\/p>\n<h2>Why Writing Clinical Study Materials From Early Protocol Versions Works<\/h2>\n<p>Early writing can help reduce the crush of work that follows protocol approval and give teams the clarity they need to make early decisions about format, flow, and workload.<\/p>\n<p>When handled with a thorough check after the protocol is approved, early writing becomes one of the simplest ways to keep study materials accurate, aligned, and on schedule.<\/p>\n<p>Writing without an approved protocol is not the ideal way to work, and we don\u2019t recommend it as a standard process. But early writing can be effective when it\u2019s supported by clear version control and a disciplined reconciliation process. With the right checks in place once the protocol is approved, teams can use early drafts to maintain momentum without compromising accuracy.<\/p>\n<h2>How Imperial Supports Early Writing<\/h2>\n<p>Imperial\u2019s writers, editors, and designers work directly from draft protocols when early writing makes sense and the protocol structure is reasonably stable. When the approved protocol arrives, we perform a full reconciliation across every piece to ensure accuracy before materials move into production.<\/p>\n<p>This disciplined approach can help meet timelines and give study teams confidence that all participant and site materials reflect the final approved protocol.<\/p>\n<p>If your protocol is still moving through reviews, it may be a good time for Imperial to begin shaping your materials so you\u2019re not starting from zero when the final version arrives. We\u2019re happy to discuss your timeline and determine whether early writing is appropriate for your study.<\/p>\n<h2>Quick Q&amp;A: Common Questions About Early Writing<\/h2>\n<h4>\u00a0 \u00a0 1. Can study materials be written before the protocol is finalized?<\/h4>\n<p>Yes. While the ideal time to write is after approval, early writing can be considered when the protocol\u2019s core structure is stable and the review period is lengthy. The key is understanding that all early drafts will require a full reconciliation once the final protocol arrives.<\/p>\n<h4>\u00a0 \u00a0 2. What parts of the protocol need to be stable before early writing begins?<\/h4>\n<p>The visit schedule, major assessments, and overall study flow should be reasonably established. These elements shape both digital and print materials, so they need to be far enough along that major structural changes are unlikely.<\/p>\n<h4>\u00a0 \u00a0 3. What are the advantages of starting early?<\/h4>\n<p>Early writing helps teams maintain momentum and reduces the volume of work that typically accumulates after protocol approval. It also provides early visibility into format, layout, and word-count needs. This is especially helpful for print pieces that require specific space and design considerations.<\/p>\n<h4>\u00a0 \u00a0 4. How do teams ensure accuracy if they start from a draft protocol?<\/h4>\n<p>Accuracy comes from disciplined version control and a full, line\u2011by\u2011line reconciliation once the protocol is approved. Every piece, no matter how simple, should be reviewed against the final protocol to ensure all details match.<\/p>\n<p>&nbsp;<\/p>\n<div style=\"display: inline-block;\"><a class=\"rss-btn\" href=\"https:\/\/cta-service-cms2.hubspot.com\/web-interactives\/public\/v1\/track\/click?encryptedPayload=AVxigLJ9SLa2bvUwdi1tBETVQK%2B9Gmqcz49dIGJe96y8nf4%2Frf%2BIfT8tW1CFtlQZ7JW8VpsCZl3ujF7X4ytPh%2B%2BZ%2F0AHJzkApE%2B9N2vyn9%2F5O4zaeVN6mIB%2FAbWP0U1YuFF%2FQI2kgNGNa419FEOGUw8IuHE3%2B35VUlcM4%2FSml6%2FP7vNUKMa9jTALctqjR8OfSoyaJRPSmLaCm4RKAg%3D%3D&amp;portalId=47151227\" target=\"_blank\" rel=\"noopener\">Sign Up For Imperial Blog Alerts<\/a><\/div>\n<div style=\"display: inline-block; margin-left: 10px;\"><a class=\"contact-btn\" href=\"https:\/\/cta-service-cms2.hubspot.com\/web-interactives\/public\/v1\/track\/click?encryptedPayload=AVxigLIXv5GY4HUfMMix9h0VI9sOaTImjv4pgG%2B9tEb8pF0QrnPWpu7rElHRDIe6N86faZhHmihNHYYxByGLhQCBcxpZ%2Bwh7p6xtBsd%2FHfG2roid%2FRh1KknuhHB3UDk7txpRnB7k3v0chxT%2BF7rlGdwr%2FV75YbfEywhd413UaCY2fcn%2F2ELk%2B28AanVoKrjbNnoMpuP6QDSqLGNdSg%3D%3D&amp;portalId=47151227\" target=\"_blank\" rel=\"noopener\">Contact Us<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Clinical studies follow established timelines, and the work of preparing site and participant materials typically begins at a predictable point in that process. Most study teams assume writing begins only after the protocol is approved, and often don\u2019t consider alternatives. Naturally, the best time to&hellip;<\/p>\n","protected":false},"author":52,"featured_media":72112,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[365],"tags":[83,465,685,37,575,680],"class_list":["post-72101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trial-writing-and-design","tag-clinical-research","tag-clinical-research-strategies","tag-clinical-study-materials","tag-clinical-trial-materials","tag-clinical-trial-planning","tag-research-study-startup"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Writing Clinical Study Materials: When Starting Early Makes Sense<\/title>\n<meta name=\"description\" content=\"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Writing Clinical Study Materials: When Starting Early Makes Sense\" \/>\n<meta property=\"og:description\" content=\"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T13:34:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"686\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liz Wegner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liz Wegner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/\"},\"author\":{\"name\":\"Liz Wegner\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/feb0dae63adaff01802c2753efb4fa17\"},\"headline\":\"Writing Clinical Study Materials: Why Starting Early Can Be an Option\",\"datePublished\":\"2026-05-06T13:34:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/\"},\"wordCount\":1052,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Writing-Clinical-Trial-Materials.jpg\",\"keywords\":[\"Clinical Research\",\"Clinical Research Strategies\",\"Clinical Study Materials\",\"Clinical Trial Materials\",\"Clinical Trial Planning\",\"Research Study Startup\"],\"articleSection\":[\"Clinical Trial Writing and Design\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/\",\"name\":\"Writing Clinical Study Materials: When Starting Early Makes Sense\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Writing-Clinical-Trial-Materials.jpg\",\"datePublished\":\"2026-05-06T13:34:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/feb0dae63adaff01802c2753efb4fa17\"},\"description\":\"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Writing-Clinical-Trial-Materials.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Writing-Clinical-Trial-Materials.jpg\",\"width\":1200,\"height\":686,\"caption\":\"Clinical trial professionals with a study calendar being crossed off and a laptop being used to write research materials\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/clinical-trial-writing-and-design\\\/writing-clinical-trial-materials-from-early-protocol-versions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Writing Clinical Study Materials: Why Starting Early Can Be an Option\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/feb0dae63adaff01802c2753efb4fa17\",\"name\":\"Liz Wegner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g\",\"caption\":\"Liz Wegner\"},\"description\":\"As project manager III and supervisor at Imperial Clinical Research Services, Liz brings a practical, detail-oriented approach to project management and a focus on clear communication that helps study teams stay aligned and on track. Based in Imperial\u2019s Michigan office, she has managed global clinical trial projects since joining the company in 2021 and works closely with cross functional teams to support the development of digital and print patient- and site-facing materials.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/lwegner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Writing Clinical Study Materials: When Starting Early Makes Sense","description":"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/","og_locale":"en_US","og_type":"article","og_title":"Writing Clinical Study Materials: When Starting Early Makes Sense","og_description":"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.","og_url":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2026-05-06T13:34:17+00:00","og_image":[{"width":1200,"height":686,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg","type":"image\/jpeg"}],"author":"Liz Wegner","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liz Wegner","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/"},"author":{"name":"Liz Wegner","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/feb0dae63adaff01802c2753efb4fa17"},"headline":"Writing Clinical Study Materials: Why Starting Early Can Be an Option","datePublished":"2026-05-06T13:34:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/"},"wordCount":1052,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg","keywords":["Clinical Research","Clinical Research Strategies","Clinical Study Materials","Clinical Trial Materials","Clinical Trial Planning","Research Study Startup"],"articleSection":["Clinical Trial Writing and Design"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/","url":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/","name":"Writing Clinical Study Materials: When Starting Early Makes Sense","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg","datePublished":"2026-05-06T13:34:17+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/feb0dae63adaff01802c2753efb4fa17"},"description":"Explore insights on writing clinical study materials from early protocol versions to build momentum and get in front of study needs.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2026\/05\/Writing-Clinical-Trial-Materials.jpg","width":1200,"height":686,"caption":"Clinical trial professionals with a study calendar being crossed off and a laptop being used to write research materials"},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/clinical-trial-writing-and-design\/writing-clinical-trial-materials-from-early-protocol-versions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Writing Clinical Study Materials: Why Starting Early Can Be an Option"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/feb0dae63adaff01802c2753efb4fa17","name":"Liz Wegner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b8e4a7cd25e51dc6e016136bbe9455c8456444b6625d04781ade42c1143ff5c4?s=96&d=mm&r=g","caption":"Liz Wegner"},"description":"As project manager III and supervisor at Imperial Clinical Research Services, Liz brings a practical, detail-oriented approach to project management and a focus on clear communication that helps study teams stay aligned and on track. Based in Imperial\u2019s Michigan office, she has managed global clinical trial projects since joining the company in 2021 and works closely with cross functional teams to support the development of digital and print patient- and site-facing materials.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/lwegner\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=72101"}],"version-history":[{"count":15,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72101\/revisions"}],"predecessor-version":[{"id":72120,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/72101\/revisions\/72120"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/72112"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=72101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=72101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=72101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}